CDMRP Vision Research Program Technology/Therapeutic Development Award

The VRP TTDA is intended to provide support for the translation of promising preclinical findings into products for clinical applications, including detection, diagnosis, treatment, or quality of life. The product(s) to be developed may be a tangible item such as a pharmacologic agent (drugs or biologics) or device, or a knowledge-based product such as clinical guidance for standard of care.

applications must address one or more of the Capability Gaps listed below:

• Inadequate mitigation and treatment of damage to ocular structures and the visual system consequent to military-relevant injuries and diseases incident to military service.

• Inadequate vision restoration and regeneration.

• Lack of knowledge, capabilities, and equipment for early responders to diagnose and mitigate military-relevant eye injuries and diseases in austere or remote environments.

Funding: $2,100,000 total 

Duration: 3 years

Research Authority due date: 5.7.17

Pre application (required) due date: 12.7.17

Full application due date: 25.10.17